Biweekly administration in two diferent dose levels of irinotecan (CPT-11), in patients with advanced colorectal cancer (CRC), according to toxicity prognostic factors.: A phase II trial.

被引：0

作者：

Saigí, E

Salut, A

Campos, JM

Manzano, H

Batiste-Alentom, E

Arcusa, A

Losa, F

Vélez, E

Guasch, I

Gallego, O

机构：

[1] H Parc Tauli, Sabadell, Spain

[2] H Arnau de Vilanova, Lleida, Spain

[3] H Arnau de Vilanova, Valencia, Spain

[4] H Son Dureta, Palma de Mallorca, Spain

[5] H Gen Vic, Vic, Spain

[6] H Gen Terrassa, Terrassa, Spain

[7] H San Millan San Pedro, Logrono, Spain

[8] Ctr Hosp & Cardiol, Manresa, Spain

[9] H Comarcal Selva, Blanes, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

189P

引用

页码：44 / 44

页数：1